BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8612254)

  • 1. Opportunity lost: a frontline view of reference-based pricing.
    Woollard RF
    CMAJ; 1996 Apr; 154(8):1185-8. PubMed ID: 8612254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference based pricing for provincial drug benefit programs.
    McLaughlin PR
    Can J Cardiol; 1996 Jan; 12(1):16, 25-6. PubMed ID: 8595565
    [No Abstract]   [Full Text] [Related]  

  • 3. Why is calling an ACE an ACE so controversial? Evaluating reference-based pricing in British Columbia.
    Anis A
    CMAJ; 2002 Mar; 166(6):763-4. PubMed ID: 11944763
    [No Abstract]   [Full Text] [Related]  

  • 4. Reference-based pricing: will other provinces follow the BC lead?
    Mullens A
    CMAJ; 1998 Jan; 158(2):239-41. PubMed ID: 9469150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.
    Schneeweiss S; Soumerai SB; Maclure M; Dormuth C; Walker AM; Glynn RJ
    Clin Pharmacol Ther; 2003 Oct; 74(4):388-400. PubMed ID: 14534526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug costs should be lower. Hessian colleagues beaten without compassion].
    MMW Fortschr Med; 2004 Jul; 146(27-28):49. PubMed ID: 15526667
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating reference-based pricing: initial findings and prospects.
    Narine L; Senathirajah M; Smith T
    CMAJ; 1999 Aug; 161(3):286-8. PubMed ID: 10463052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New cost saving legislation for drugs. National health insurance carriers do not want to believe Ulla Schmidt}].
    MMW Fortschr Med; 2006 Feb; 148(5):45. PubMed ID: 16518939
    [No Abstract]   [Full Text] [Related]  

  • 9. [Limited prescribing freedom by federal cost regulation?].
    Lasek R
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):633-5. PubMed ID: 9527458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Implementation of "aut idem" before and after introduction of rebate contracts].
    Hoffmann F; Windt R; Glaeske G
    Dtsch Med Wochenschr; 2010 Apr; 135(15):739-44. PubMed ID: 20373270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Class substitution as an instrument of efficiency in the supply of medicines: possibilities and limitations].
    de Smet PA; van der Kuy A; Bonsel GJ
    Ned Tijdschr Geneeskd; 2002 Mar; 146(12):553-7. PubMed ID: 11938577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization.
    Schneeweiss S; Soumerai SB; Glynn RJ; Maclure M; Dormuth C; Walker AM
    CMAJ; 2002 Mar; 166(6):737-45. PubMed ID: 11944760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing data and cost comparisons in New Zealand.
    Bishop N; Maling T
    N Z Med J; 1997 Nov; 110(1056):445-6. PubMed ID: 9418844
    [No Abstract]   [Full Text] [Related]  

  • 15. [Can physicians really save still more in drug prescriptions?].
    Schmidt K
    MMW Fortschr Med; 2006 Feb; 148(5):44-5. PubMed ID: 16518938
    [No Abstract]   [Full Text] [Related]  

  • 16. A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia.
    Grootendorst P; Stewart D
    Health Econ; 2006 Jul; 15(7):735-42. PubMed ID: 16498702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference-based pricing in British Columbia: implications for cardiologists--an analysis.
    Boulet AP; Tessier G
    Can J Cardiol; 1997 Jan; 13(1):46-51. PubMed ID: 9039064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs.
    Grootendorst PV; Dolovich LR; O'Brien BJ; Holbrook AM; Levy AR
    CMAJ; 2001 Oct; 165(8):1011-9. PubMed ID: 11699696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [[Prescriptions for psychotropic drugs: results and comments on the 2007 prescription drug report].
    Fritze J
    Nervenarzt; 2008 Nov; 79(11):1337-45. PubMed ID: 19002733
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prescriptions for psychotropic drugs: results and comments on the 2005 prescription drug report].
    Fritze J
    Nervenarzt; 2006 Mar; 77(3):376-83. PubMed ID: 17078120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.